Concurrent Training and Prediabetes Control

May 29, 2018 updated by: Universidad Santo Tomas

Concurrent Training and Prediabetes Comorbidities: An Analysis of Non-responders Using Clinical Cutoff Points

Despite exercise training decrease blood fasting glicaemy in 'average' terms, there is a wide inter-individual variability after exercise training explored mainly in adults but not in adults with prediabetes comorbidities. Thus, is yet unknown the effects and influence of the concurrent training (CT) eliciting responders (R) and non-responders (NR) cases (i.e., percentage of subjects who experienced a non-change/worsened response after training in some metabolic outcomes).

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Osorno
      • Los Lagos, Osorno, Chile, 000000000
        • Cristian ALvarez

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 59 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Written informed consent.
  • Interested in improving health and fitness.

Exclusion Criteria:

  • Cardiovascular contraindications to exercise,
  • History of stroke, asthma or chronic obstructive pulmonary disease,
  • Muscle-skeletal disorders, and
  • Smoking.
  • A compliance rate to the exercise program ≥ 70% was required for the participants in the intervention group to be included in the statistical analyses.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
No-exercise
CT in women with prediabetes and co-morbidities associated. Exercise will be performed at three sessions per week. Post statistical analyses will be including analyses by the 2 groups proposed. All sessions will be supervised by an exercise physiologist during 20-weeks.
Experimental: Endurance training plus resistant training
To concurrent training (endurance training plus resistant training, RT) program will be use cycle ergometers adapted for obese adults (OXFORDTM, model BE2601, OXOFORD Inc, Santiago, Chile) were used. Prior to the CT intervention, all subjects were familiarized (during 3 sessions) with the training protocols. The CT intervention included 3 weekly sessions of both ET and RT. The core part of each session included RT followed by ET exercises (for 50 and 30 minutes, respectively) and was preceded and followed by a 5-minute warm-up and cool-down with callisthenic movements.
CT in women with prediabetes and co-morbidities associated. Exercise will be performed at three sessions per week. Post statistical analyses will be including analyses by the 2 groups proposed. All sessions will be supervised by an exercise physiologist during 20-weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fasting glucose
Time Frame: Baseline and 20-weeks immediately after the interventions ends
Change from Baseline in fasting glucose
Baseline and 20-weeks immediately after the interventions ends
Lipoproteins
Time Frame: Baseline and 20-weeks immediately after the interventions ends
Change from baseline in lipoproteins
Baseline and 20-weeks immediately after the interventions ends

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body mass
Time Frame: Baseline and 20-weeks immediately after the interventions ends
Change from Baseline in body mass
Baseline and 20-weeks immediately after the interventions ends
Waist circumference
Time Frame: Baseline and 20-weeks immediately after the interventions ends
Change from Baseline in waist circumference
Baseline and 20-weeks immediately after the interventions ends
Fat mass
Time Frame: Baseline and 20-weeks immediately after the interventions ends
Change from Baseline in fat mass
Baseline and 20-weeks immediately after the interventions ends
Lean mass
Time Frame: Baseline and 20-weeks immediately after the interventions ends
Change from Baseline in lean mass
Baseline and 20-weeks immediately after the interventions ends
Heart rate at rest
Time Frame: Baseline and 20-weeks immediately after the interventions ends
Change from Baseline in heart rate at rest
Baseline and 20-weeks immediately after the interventions ends
Six minutes walking test
Time Frame: Baseline and 20-weeks immediately after the interventions ends
Change from Baseline in six minutes walking test
Baseline and 20-weeks immediately after the interventions ends

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cristian Alvarez, PhD, Universidad de Los Lagos

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2017

Primary Completion (Actual)

April 9, 2018

Study Completion (Actual)

April 9, 2018

Study Registration Dates

First Submitted

April 9, 2018

First Submitted That Met QC Criteria

April 17, 2018

First Posted (Actual)

April 18, 2018

Study Record Updates

Last Update Posted (Actual)

May 31, 2018

Last Update Submitted That Met QC Criteria

May 29, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Disturbance

Clinical Trials on Endurance training plus resistant training

3
Subscribe